Key statistics
On Monday, Mediwound Ltd (M8W:FRA) closed at 15.00, -26.47% below its 52-week high of 20.40, set on Jul 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.00 |
---|---|
High | 15.00 |
Low | 15.00 |
Bid | 14.70 |
Offer | 15.20 |
Previous close | 14.80 |
Average volume | 67.75 |
---|---|
Shares outstanding | 10.79m |
Free float | 8.65m |
P/E (TTM) | -- |
Market cap | 180.35m USD |
EPS (TTM) | -2.16 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 07:19 BST.
More ▼
- MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update
- MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)
- MediWound to Report Second Quarter 2024 Financial Results
- MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
- MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
- MediWound Announces $25 Million Strategic Private Placement Financing
- MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
- MediWound to Report First Quarter 2024 Financial Results
More ▼